Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Real-world Outcomes in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck With Nivolumab: Galician Study

LETICIA IGLESIAS, ROCÍO VÍLCHEZ, SANTIAGO AGUÍN, RAMÓN GARCÍA, CAROLINA PENA, ALBERTO CARRAL, GERARDO HUIDOBRO, AUREA MOLINA, JESÚS GARCÍA GÓMEZ, MARTA COVELA, MARINHA COSTA and ANA MEDINA
Anticancer Research March 2025, 45 (3) 1181-1191; DOI: https://doi.org/10.21873/anticanres.17505
LETICIA IGLESIAS
1Department of Medical Oncology, Complejo Hospitalario Universitario de Ourense (CHUO), Ourense, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: leticia.iglesias.rey@sergas.es
ROCÍO VÍLCHEZ
2Department of Medical Oncology, Complejo Hospitalario Universitario de Ferrol (CHUF), A Coruña, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SANTIAGO AGUÍN
3Department of Medical Oncology, Complejo Hospitalario Universitario de Santiago de Compostela (CHUS), A Coruña, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RAMÓN GARCÍA
4Department of Medical Oncology, Complejo Hospitalario Universitario de Pontevedra (CHOP), Pontevedra, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CAROLINA PENA
5Department of Medical Oncology, Fundación Centro Oncológico de Galicia (COG), A Coruña, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALBERTO CARRAL
6Department of Medical Oncology, Hospital Universitario Lucus Augusti (HULA), Lugo, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GERARDO HUIDOBRO
7Department of Medical Oncology, Complejo Hospitalario Universitario de Vigo (CHUVI), Pontevedra, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AUREA MOLINA
8Department of Medical Oncology, Complejo Universitario de A Coruña (CHUAC), A Coruña, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JESÚS GARCÍA GÓMEZ
1Department of Medical Oncology, Complejo Hospitalario Universitario de Ourense (CHUO), Ourense, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARTA COVELA
6Department of Medical Oncology, Hospital Universitario Lucus Augusti (HULA), Lugo, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARINHA COSTA
9Department of Medical Oncology, Hospital Ribera POVISA, Pontevedra, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANA MEDINA
5Department of Medical Oncology, Fundación Centro Oncológico de Galicia (COG), A Coruña, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 45 no. 3 1181-1191
DOI 
https://doi.org/10.21873/anticanres.17505
PubMed 
40037864

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received January 13, 2025
  • Revision received January 28, 2025
  • Accepted January 30, 2025
  • Published online March 4, 2025.

Copyright & Usage 
Copyright © 2025 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. LETICIA IGLESIAS1⇑,
  2. ROCÍO VÍLCHEZ2,
  3. SANTIAGO AGUÍN3,
  4. RAMÓN GARCÍA4,
  5. CAROLINA PENA5,
  6. ALBERTO CARRAL6,
  7. GERARDO HUIDOBRO7,
  8. AUREA MOLINA8,
  9. JESÚS GARCÍA GÓMEZ1,
  10. MARTA COVELA6,
  11. MARINHA COSTA9 and
  12. ANA MEDINA5
  1. 1Department of Medical Oncology, Complejo Hospitalario Universitario de Ourense (CHUO), Ourense, Spain;
  2. 2Department of Medical Oncology, Complejo Hospitalario Universitario de Ferrol (CHUF), A Coruña, Spain;
  3. 3Department of Medical Oncology, Complejo Hospitalario Universitario de Santiago de Compostela (CHUS), A Coruña, Spain;
  4. 4Department of Medical Oncology, Complejo Hospitalario Universitario de Pontevedra (CHOP), Pontevedra, Spain;
  5. 5Department of Medical Oncology, Fundación Centro Oncológico de Galicia (COG), A Coruña, Spain;
  6. 6Department of Medical Oncology, Hospital Universitario Lucus Augusti (HULA), Lugo, Spain;
  7. 7Department of Medical Oncology, Complejo Hospitalario Universitario de Vigo (CHUVI), Pontevedra, Spain;
  8. 8Department of Medical Oncology, Complejo Universitario de A Coruña (CHUAC), A Coruña, Spain;
  9. 9Department of Medical Oncology, Hospital Ribera POVISA, Pontevedra, Spain
  1. Dr. Leticia Iglesias, Complejo Hospitalario Universitario de Ourense (CHUO), Ourense, Spain. Tel: +34 988385479, e-mail: leticia.iglesias.rey{at}sergas.es
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 45 (3)
Anticancer Research
Vol. 45, Issue 3
March 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Real-world Outcomes in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck With Nivolumab: Galician Study
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Real-world Outcomes in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck With Nivolumab: Galician Study
LETICIA IGLESIAS, ROCÍO VÍLCHEZ, SANTIAGO AGUÍN, RAMÓN GARCÍA, CAROLINA PENA, ALBERTO CARRAL, GERARDO HUIDOBRO, AUREA MOLINA, JESÚS GARCÍA GÓMEZ, MARTA COVELA, MARINHA COSTA, ANA MEDINA
Anticancer Research Mar 2025, 45 (3) 1181-1191; DOI: 10.21873/anticanres.17505

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Real-world Outcomes in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck With Nivolumab: Galician Study
LETICIA IGLESIAS, ROCÍO VÍLCHEZ, SANTIAGO AGUÍN, RAMÓN GARCÍA, CAROLINA PENA, ALBERTO CARRAL, GERARDO HUIDOBRO, AUREA MOLINA, JESÚS GARCÍA GÓMEZ, MARTA COVELA, MARINHA COSTA, ANA MEDINA
Anticancer Research Mar 2025, 45 (3) 1181-1191; DOI: 10.21873/anticanres.17505
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Comparison of BRCA2 Single Nucleotide Variants Between Japanese Patients With Familial Prostate Cancer, Sporadic Prostate Cancer, and Benign Prostatic Hyperplasia
  • Corrigendum
  • Sex-related Survival Differences in Patients With Glioblastoma – Results From a Retrospective Analysis
Show more Clinical Studies

Similar Articles

Keywords

  • nivolumab
  • recurrent or metastatic disease
  • squamous cell carcinoma of the head and neck
  • real-life data
  • adverse events
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire